Elevated creatine kinase
Reading File
Finding Sources
Searching PubMed
"creatine kinase" AND "elevated" AND diagnosis
Reading File
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
Reading File
Finding Sources
Finding Sources
I now have comprehensive material from the textbooks. Let me compile the full answer.
Elevated Creatine Kinase (Hypercreatine Kinasemia / HyperCKemia)
What Is CK?
Creatine kinase (CK) is a dimeric enzyme (82 kDa) that catalyzes the reversible phosphorylation of creatine by ATP. It is found in highest concentrations in striated muscle (~2500 U/g protein) and cardiac muscle (~550 U/g), with lesser amounts in brain and smooth muscle. The liver and red blood cells are essentially devoid of CK activity. Because of its tissue specificity, serum CK is a reliable surrogate marker of muscle membrane integrity.
- Tietz Textbook of Laboratory Medicine, 7th Ed
- Bradley and Daroff's Neurology in Clinical Practice
Isoenzymes
CK exists as a dimer of two subunits (B and M), producing three cytosolic isoforms:
| Isoenzyme | Composition | Primary Source |
|---|---|---|
| CK-MM (CK-3) | MM | Skeletal muscle (~97-98% of serum CK) |
| CK-MB (CK-2) | MB | Myocardium (also minor skeletal muscle) |
| CK-BB (CK-1) | BB | Brain, smooth muscle |
| CK-Mt | Mitochondrial | Mitochondrial (separate immunologically) |
A fourth species, macro-CK, is a complex of CK (usually CK-BB) with an immunoglobulin (often IgG). Macro-CK type 1 is not pathologically significant but can cause spuriously elevated total CK.
Reference Ranges
Normal values differ substantially by race, sex, and physical activity. Upper limits of normal (97.5th percentile) are approximately:
| Group | Upper Limit (U/L) |
|---|---|
| Black men | 520 |
| Black women / non-Black men | 345 |
| Non-Black women | 145 |
African American males and young athletic men have the highest baseline CK levels; non-African American women the lowest. 2.5% of the normal population will exceed the upper limit by definition, so isolated mild elevation requires clinical context.
- Bradley and Daroff's Neurology in Clinical Practice, p. 496
Causes of Elevated CK
1. Physiological / Benign
- Strenuous exercise or trauma - most common; typically transient, normalizes within 1-3 days
- Race and sex variation (as above)
- Macro-CK - spurious elevation, no clinical significance
2. Skeletal Muscle Disease (Primary Myopathies)
CK is generally highest when disease is rapid-onset or diffuse:
| Condition | Typical CK Level |
|---|---|
| Rhabdomyolysis | Often >100,000 U/L |
| Dystrophinopathies (Duchenne/Becker MD) | Very high (10-100x normal); also in female carriers (asymptomatic) |
| Polymyositis / dermatomyositis | Moderately-markedly elevated |
| Immune-mediated necrotizing myopathy (IMNM) | Profoundly elevated (often >10,000 U/L) |
| Limb-girdle muscular dystrophies (LGMD) | Variable |
| Toxic myopathies | Variable to high |
Conditions that may show normal or mildly elevated CK despite significant weakness include: facioscapulohumeral (FSH) muscular dystrophy, inclusion body myositis, metabolic myopathies, myotonic dystrophy, oculopharyngeal muscular dystrophy (OPMD), and chronic/focal muscle disease.
- Bradley and Daroff's Neurology in Clinical Practice
3. Cardiac Disease
- Myocardial infarction - CK-MB rises within 4-8 hours, peaks at 18-24 hours. However, cardiac troponins (TnI, TnT) have superseded CK-MB as the preferred marker for MI due to superior specificity.
4. Drug-Induced
- Statins - most common iatrogenic cause. Asymptomatic hyperCKemia occurs in ~5% of users. Severe myopathy (<0.1%) and rhabdomyolysis (~2-3/100,000 patients) are rare. Statins can also trigger autoimmune anti-HMG-CoA reductase myopathy (IMNM) with profound CK elevations. Action threshold: discontinue if CK >10x ULN with symptoms.
- Fibrates, niacin - increased myopathy risk, especially when combined with statins
- Antifungals (azoles), macrolides, ciclosporin - increase statin exposure, compounding risk
- Alcohol and drugs of abuse - common contributing factors to rhabdomyolysis
- Nucleoside analogs (telbivudine, lamivudine, entecavir) - asymptomatic CK elevation most common
5. Metabolic / Endocrine
- Hypothyroidism - a classic but often overlooked cause; CK may be 10-100x normal
- Hypokalemia, hypophosphatemia - can cause myopathy with CK elevation
- Diabetic ketoacidosis - associated with elevated CK
6. Rhabdomyolysis (Severe Muscle Breakdown)
Rhabdomyolysis is defined by myonecrosis with release of muscle cell contents (myoglobin, CK, potassium, phosphate, uric acid) into the circulation. CK >5x ULN in the right clinical setting supports the diagnosis; levels >100,000 U/L are not uncommon. Risk factors for drug-induced rhabdomyolysis include: frailty, low BMI, hypertension, renal insufficiency, vitamin D deficiency, hypothyroidism, advanced age, female sex, and alcohol/drug use.
The McMahon Score is used to risk-stratify rhabdomyolysis for acute kidney injury (AKI). A score ≥6 is "not low risk" and warrants aggressive IV fluid resuscitation (target urine output 1-2 mL/kg/hr).
- Goldman-Cecil Medicine
7. Neurological
- Spinal muscular atrophy (SMA) and ALS may rarely elevate CK up to ~10x normal
- Neurogenic atrophy (denervation) - generally mild elevation
8. Infectious / Inflammatory
- Viral myositis (influenza, enteroviruses) - common in children; benign acute childhood myositis
- Bacterial infections with sepsis
- COVID-19 - myositis and rhabdomyolysis have been reported
9. Other
- Trauma, surgery, immobilization, seizures, heat stroke, malignant hyperthermia - all can produce dramatic CK elevations
- Malignant hyperthermia and neuroleptic malignant syndrome - life-threatening causes
Interpretation Pearls
- Transient vs. sustained elevation: Transient rises after exercise/trauma are benign. A CK that does not decline by ~50% every 2 days suggests ongoing muscle damage.
- CK may be normal in chronic/focal myopathies despite significant weakness.
- Aldolase, LDH, AST/ALT can also be elevated in myositis, but none is as muscle-specific as CK. Isolated elevated AST in a muscular patient may reflect CK-related muscle disease rather than liver pathology.
- CK-MM (skeletal subtype) dominates in skeletal muscle disease; CK-MB >5% of total CK suggests cardiac injury.
- Routine CK monitoring is not recommended for statin-treated patients without symptoms (2018 AHA/ACC guideline).
Approach to Workup
- Confirm and quantify - repeat fasting CK, check isoenzymes if cardiac cause suspected
- Rule out physiological causes - recent strenuous exercise, trauma, intramuscular injection
- Medication review - statins, fibrates, antifungals, nucleoside analogs, alcohol
- Thyroid function (TSH) - hypothyroidism is common and reversible
- Electrolytes - potassium, phosphate, calcium
- Urinalysis - dipstick positive for blood without RBCs on microscopy = suspect myoglobinuria/rhabdomyolysis
- Assess for end-organ damage - BMP/creatinine for AKI (rhabdomyolysis risk)
- Autoimmune panel - if inflammatory myopathy suspected: anti-Jo-1, anti-Mi-2, anti-SRP, anti-HMGCR
- EMG + muscle biopsy - for persistent unexplained elevation or progressive weakness
- Genetic testing - if muscular dystrophy pattern
Recent literature note: A 2024 review on immune-mediated necrotizing myopathy (IMNM) highlights the importance of anti-SRP and anti-HMGCR antibodies in statin-associated and idiopathic cases (PMID 39033686). A 2025 review on dystrophinopathies emphasizes the role of genetic testing in evaluating hyperCKemia (PMID 41037163).
This is a shared conversation. Sign in to Orris to start your own chat.